Navigation Links
Iowa Medicaid Demonstration Finds Tel-Assurance(R) Remote Monitoring Platform Improved Health Status and Saved $5 Million
Date:7/8/2008

Heart Failure Study Validates Use of Pharos Innovation's Proprietary, Device-Free Remote Monitoring Platform to Reduce Healthcare Utilization and

Medical Costs

NORTHFIELD, Ill., July 8 /PRNewswire/ -- Pharos Innovations, a pioneer in assisting clients to achieve next generation clinical and financial performance improvement through a device-free remote monitoring platform, announced today the results from the Iowa Medicaid Congestive Heart Failure Population Disease Management Demonstration. The one year demonstration, conducted between October, 2006 and October, 2007 confirmed that Pharos Innovations' Tel-Assurance remote monitoring platform reduced the need for costly acute care services, saving Iowa Medicaid nearly $3 million. In addition, the demonstration confirmed an additional $2 million costs had the interventions not been applied -- for a total of $5 million savings versus trend.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080306/AQTH086LOGO)

"These results represent a breakthrough in the management of complex chronic conditions," said Dr. Randall Williams, CEO and founder of Pharos Innovations. "It proves that this new model of daily, proactive patient monitoring can demonstrate dramatically different results than traditional disease management has shown."

The demonstration results, which were compiled by the project steering committee, validated by a comprehensive evaluation plan and certified through the Disease Management Purchasing Consortium (DMPC), the largest source of contracting assistance in disease and population management, include:

-- Nearly $3 million savings from reduced healthcare service utilization for the participant group, compared to a $2 million increase for the matched cohort group

-- 24% reduction in hospital admissions, compared to a 22% increase for the matched cohort group

-- 22% decrease in total bed days, compared to a 33% increase for the matched cohort group

-- 2x increase in the size of care managers' case loads due to program efficiencies

Iowa Medicaid Enterprises (IME); the Iowa Chronic Care Consortium (ICCC), a voluntary collaboration of public, private, academic and government organizations whose purpose is to develop capacity for the state of Iowa to effectively manage the most prevalent chronic diseases affecting Iowans, and Pharos Innovations partnered for this demonstration. It was launched to evaluate the impact of Tel-Assurance, a scalable, cost-effective and proven remote monitoring platform, in reducing cost and improving quality, self-management and care coordination for Iowa Medicaid members with heart failure.

"We know that involving patients in their care empowers them and encourages the adoption of healthier lifestyles and behaviors," said Dr. Tom Kline, IME medical director. "This demonstration showed that implementing a technology-leveraged chronic care model, such as Tel-Assurance, can transform care coordination from episodic, reactive and human resource based to a daily, proactive, efficient and self-care supportive model."

"These results indicate that a communication- and technology-based remote monitoring platform can transform care coordination, even for the challenging Medicaid population, to encourage the adoption of healthier lifestyles and produce industry-leading clinical and financial performance improvements," added William Appelgate, Ph.D., executive director of the ICCC.

The one year study, notable for its industry best practice level methodology, used a one year baseline and compared program participants to a matched cohort group. Due to the demonstration's success in saving money and improving care, Iowa Medicaid will extend the use of the program beyond the demonstration.

For a copy of the detailed Project Evaluation Report or for more information about the demonstration results, please contact Bonni Kaplan, senior director of marketing and communications at Pharos Innovations, at (847) 790-7649 or bkaplan@pharosinnovations.com.

About Pharos Innovations

Founded in 1995, Pharos Innovations assists healthcare providers and payers in achieving next generation clinical and financial performance improvement. An innovative, device-free platform, Tel-Assurance(R), improves care coordination and drives dramatic clinical improvement and cost savings by remotely monitoring patients and averting unnecessary clinical events. Our enabling technologies proactively involve patients in their care and result in the early identification of clinical deterioration.

Tel-Assurance substantially expands the reach, efficiency and effectiveness of clients' current health management programs for complex chronic conditions. The Pharos solution is strongly validated to show measured clinical improvement and financial impact, is the recipient of the prestigious American Heart Association National Outcomes award and was selected for the first ever National Institutes of Health (NIH) sponsored evaluation of remote monitoring interventions. For more information visit http://www.pharosinnovations.com or call (847) 881-8705.

Contact: Bonni L. Kaplan

Pharos Innovations

847-790-7649

bkaplan@pharosinnovations.com


'/>"/>
SOURCE Pharos Innovations
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Patients with Medicaid and those lacking insurance have higher risk of advanced laryngeal cancer
2. ACS Announces Contract Extensions with Hawaii Medicaid
3. E-Prescribing Saving Mississippi Medicaid $1.2 Million Per Month
4. Merck & Co., Inc. Response to Todays New York Medicaid Suit
5. Community Health Centers Reveal Specific Ramifications of The Medicaid Citizenship and Identification Documentation Requirements
6. ACM Helps Medicaid Programs Comply With Federal Deficit Reduction Act Mandates
7. Boise(R) BEWARE(TM) Meets New Federal Guidelines Set Forth by Medicaid
8. Health Literacy Innovations Releases New Survey on Medicaid Health Literacy Standards
9. New Study Finds Medicaid Under-Funds Long Term Care by $4.4 Billion Annually
10. Vangent, Inc. Wins Spot on Centers for Medicare & Medicaid Services Enterprise System Development Contract
11. New Study Spotlights Growing Role of Medicare in Propping Up Nations Medicaid Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , ... March 29, 2017 , ... Immunotherapy has emerged ... number of cancers and is touted to be the next revolution in our fight ... has been in the form of immune checkpoint inhibitors such as PD-1 and PD-L1 ...
(Date:3/29/2017)... PA (PRWEB) , ... March 29, 2017 , ... The ... W’80, WG’81, and Julie Taffet Moelis, W’81, have made a $10 million gift to ... deferred admission opportunity that will provide a pathway to a Wharton MBA for highly-qualified ...
(Date:3/28/2017)... ... ... Tuesday, March 28, 2017, is the annual American Diabetes Association Alert Day, ... find out if they are at risk for developing Type 2 diabetes. In recognition ... by programming the LAX pylons the color red. Downtown’s U.S. Bank Tower Crown Lights ...
(Date:3/28/2017)... ... March 28, 2017 , ... Resoundant, Inc., the developer of ... Siemens Healthineers annual customer education symposium, a world-class learning conference that offers educational ... 27 - 31, 2017 at the Atlanta Marriott Marquis in Atlanta, Georgia. , ...
(Date:3/28/2017)... Seattle, WA (PRWEB) , ... March 28, 2017 ... ... reach a 22% share of all holidays (IBT World Travel Trends Report). As ... physically challenging, include a range in temperatures, and prolonged sun exposure. In response, ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... Research and Markets has announced the addition of the ... their offering. ... The ablation device global market is expected to grow at high ... Ablation is the minimally invasive therapeutic tissue excision procedure used ... removal, to the removal of abnormally conducting cardiac tissue in atrial ...
(Date:3/29/2017)... SAN FRANCISCO , March 29, 2017 /PRNewswire/ ... an option agreement with Bionure Farma, S.L. for ... BN201 and to BN119 in the field of ... million plus sales-based royalties. The agreement provides ... stage assets with a differentiated product profile. Under ...
(Date:3/29/2017)... 29, 2017   Royal Philips (NYSE: ... technology, and PathAI, a company that develops artificial ... aim to develop solutions that improve the precision ... other diseases. The partnership aims to build deep ... of artificial intelligence to be applied to massive ...
Breaking Medicine Technology: